AUG 12, 2021 6:00 AM PDT

Computers Pick Up the 'Sound' of Thyroid Cancer

WRITTEN BY: Tara Fernandez

Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic imaging and artificial intelligence. The platform could soon make painful fine-needle aspiration biopsies a thing of the past for patients suspected to have thyroid cancer.

The thyroid is a small, butterfly-shaped gland located at the base of the neck that produces a multi-functional hormone that controls physiological processes such as heart rate and metabolism.

Around 95 percent of lumps and masses on the thyroid are found to be benign, but to rule out the slim chance of cancer, physicians perform a biopsy to extract and analyze the tissue. The problem is that this procedure is notoriously unreliable—about a fifth of the biopsies will need to be repeated due to inconclusive results.

In search of a more accurate and patient-friendly alternative, a team of Korean engineers turned to photoacoustics, a phenomenon where laser light absorbed by a substance emits sound waves. Malignant thyroid tissues have different physical properties from benign ones. For instance, they have lower oxygen saturation levels, which could then translate to different photoacoustic characteristics.

To help distinguish between the ultrasound signal outputs, the team created a machine learning platform that was ‘taught’ using data collected from patients with both malignant and benign thyroid nodules.

In their study, the team reports that the computing platform has a sensitivity of 83 percent and a specificity of 93 percent when using machine learning and conventional ultrasound assessments in parallel.

According to the researchers, this technology, the first-of-its-kind, can also be applied to diagnosing other cancers, including breast cancer. The team envisions a future whereby photoacoustic imaging of the thyroid will be a routine, needle-free part of health checkups for patients with thyroid nodules to monitor their health.

 

Source: Cancer Research.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 19, 2021
Genetics & Genomics
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
APR 19, 2021
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
Researchers have suggested that it's time for medicine to move away from demographic labels that are too narrow to captu ...
JUN 04, 2021
Cannabis Sciences
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
JUN 04, 2021
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
Researchers from contract research organization, KGK Science, working on behalf of neurotechnology firm Zentrela, have f ...
JUN 16, 2021
Clinical & Molecular DX
Rapid Screening Tool Provides Insights on Brain Health
JUN 16, 2021
Rapid Screening Tool Provides Insights on Brain Health
Scientists at King’s College London have identified a single biomarker that can be used to diagnose a range of neu ...
JUL 15, 2021
Technology
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
JUL 15, 2021
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
While there have been multiple methods of evaluating whether a patient with inflammatory bowel disease (IBD) is respondi ...
AUG 19, 2021
Clinical & Molecular DX
Biosensor Illuminates Growing Tumors and Healing Wounds
AUG 19, 2021
Biosensor Illuminates Growing Tumors and Healing Wounds
Cancerous tissues can be difficult to spot, particularly at the early stages. The malignant cells are sometimes indistin ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
Loading Comments...